Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients



Status:Completed
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - Any
Updated:11/8/2014
Start Date:August 2013
End Date:August 2014

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
Our objective is to assess whether pre-treatment with a fixed dose of insulin, based on
weight, given to pregnant patients with gestational or preexisting diabetes receiving
betamethasone can provide adequate glycemic control.

Our hypothesis is that pre-treatment with a weight-based calculated insulin dose will help
maintain euglycemia for pregnant patients with gestational and preexisting diabetes after
steroid administration, and possibly impact length of hospital admission.


Inclusion Criteria:

1. Pregnant women with gestational or pre-existing diabetes admitted to the University
of Minnesota

2. Must be 18 years or older

3. Must speak English, Spanish, or Somali

4. Patients must receive steroids for fetal lung maturity as part of their hospital
course

Exclusion Criteria:

1. Pregnant women with Type 1 Diabetes, or Type 2 diabetes with evidence of end-organ
disease

2. Pregnant women who need to be emergently delivered due to maternal or fetal
complications of pregnancy
We found this trial at
1
site
University of Minnesota Medical Center
2450 Riverside Avenue
Minneapolis, Minnesota 55455
(612) 273-3000
University of Minnesota Medical Center Improving patients' lives drives the innovation that makes University of...
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials